BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 18455982)

  • 21. PTEN: a yin-yang master regulator protein in health and disease.
    Pulido R
    Methods; 2015 May; 77-78():3-10. PubMed ID: 25843297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The functions of tumor suppressor PTEN in innate and adaptive immunity.
    Chen L; Guo D
    Cell Mol Immunol; 2017 Jul; 14(7):581-589. PubMed ID: 28603282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pills of PTEN? In and out for tumor suppression.
    Papa A; Chen M; Pandolfi PP
    Cell Res; 2013 Oct; 23(10):1155-6. PubMed ID: 23917528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-translational modifications of PTEN and their potential therapeutic implications.
    Singh G; Chan AM
    Curr Cancer Drug Targets; 2011 Jun; 11(5):536-47. PubMed ID: 21486223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assays to Measure PTEN Lipid Phosphatase Activity In Vitro from Purified Enzyme or Immunoprecipitates.
    Spinelli L; Leslie NR
    Methods Mol Biol; 2016; 1447():95-105. PubMed ID: 27514802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-genomic loss of PTEN function in cancer: not in my genes.
    Leslie NR; Foti M
    Trends Pharmacol Sci; 2011 Mar; 32(3):131-40. PubMed ID: 21236500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTEN at 18: Still Growing.
    Gorbenko O; Stambolic V
    Methods Mol Biol; 2016; 1388():13-9. PubMed ID: 27033067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antioncogene PTEN-a new target for myeloma therapy].
    Wang SY; Cheng ZY; Deng K; Chen H; Pan L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):816-20. PubMed ID: 20561457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell Cycle Control by PTEN.
    Brandmaier A; Hou SQ; Shen WH
    J Mol Biol; 2017 Jul; 429(15):2265-2277. PubMed ID: 28602818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PTEN in cancer, metabolism, and aging.
    Ortega-Molina A; Serrano M
    Trends Endocrinol Metab; 2013 Apr; 24(4):184-9. PubMed ID: 23245767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Collateral deletion of the mitochondrial AAA+ ATPase ATAD1 sensitizes cancer cells to proteasome dysfunction.
    Winter JM; Fresenius HL; Cunningham CN; Wei P; Keys HR; Berg J; Bott A; Yadav T; Ryan J; Sirohi D; Tripp SR; Barta P; Agarwal N; Letai A; Sabatini DM; Wohlever ML; Rutter J
    Elife; 2022 Nov; 11():. PubMed ID: 36409067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No association between phosphatase and tensin homolog genetic polymorphisms and colon cancer.
    Phillips LS; Thompson CL; Merkulova A; Plummer SJ; Tucker TC; Casey G; Li L
    World J Gastroenterol; 2009 Aug; 15(30):3771-5. PubMed ID: 19673018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene of the month: PTEN.
    Govender D; Chetty R
    J Clin Pathol; 2012 Jul; 65(7):601-3. PubMed ID: 22416141
    [No Abstract]   [Full Text] [Related]  

  • 34. PTEN hopping on the cell membrane is regulated via a positively-charged C2 domain.
    Yasui M; Matsuoka S; Ueda M
    PLoS Comput Biol; 2014 Sep; 10(9):e1003817. PubMed ID: 25211206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conformational stability and catalytic activity of PTEN variants linked to cancers and autism spectrum disorders.
    Johnston SB; Raines RT
    Biochemistry; 2015 Feb; 54(7):1576-82. PubMed ID: 25647146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PTEN plasticity: how the taming of a lethal gene can go too far.
    Naguib A; Trotman LC
    Trends Cell Biol; 2013 Aug; 23(8):374-9. PubMed ID: 23578748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutant PTEN in Cancer: Worse Than Nothing.
    Leslie NR; den Hertog J
    Cell; 2014 Apr; 157(3):527-9. PubMed ID: 24766800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple roles of PTEN isoforms PTENĪ± and PTENĪ² in cellular activities and tumor development.
    Liang H; Yin Y
    Sci China Life Sci; 2019 Dec; 62(12):1722-1724. PubMed ID: 31823204
    [No Abstract]   [Full Text] [Related]  

  • 39. Lloyd Trotman: of mice and men, cancer, and PTEN. Interviewed by Caitlin Sedwick.
    Trotman L
    J Cell Biol; 2008 May; 181(3):402-3. PubMed ID: 18458154
    [No Abstract]   [Full Text] [Related]  

  • 40. P-TEN exciting years: from the cytosol to the nucleus and back to keep cancer at bay.
    Pandolfi PP
    Oncogene; 2008 Sep; 27(41):5386. PubMed ID: 18794874
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.